Laboratory markers including GTP, AST, ALT, TG, HbA1c, and HOMA-IR tended to be the highest in the resolved NAFLD group (Group 5) among all groups at baseline. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.